143 related articles for article (PubMed ID: 31109310)
1. Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor.
Liu CC; Yu CF; Wang SC; Li HY; Lin CM; Wang HH; Abate C; Chiang CS
BMC Cancer; 2019 May; 19(1):473. PubMed ID: 31109310
[TBL] [Abstract][Full Text] [Related]
2. Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.
Pati ML; Hornick JR; Niso M; Berardi F; Spitzer D; Abate C; Hawkins W
BMC Cancer; 2017 Jan; 17(1):51. PubMed ID: 28086830
[TBL] [Abstract][Full Text] [Related]
3. Investigation of σ receptors agonist/antagonist activity through N-(6-methoxytetralin-1-yl)- and N-(6-methoxynaphthalen-1-yl)alkyl derivatives of polymethylpiperidines.
Niso M; Abate C; Ferorelli S; Cassano G; Gasparre G; Perrone R; Berardi F
Bioorg Med Chem; 2013 Apr; 21(7):1865-9. PubMed ID: 23415062
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.
Liu CZ; Mottinelli M; Nicholson HE; McVeigh BM; Wong NK; McCurdy CR; Bowen WD
Eur J Pharmacol; 2021 Sep; 906():174263. PubMed ID: 34144027
[TBL] [Abstract][Full Text] [Related]
5. Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).
Berardi F; Abate C; Ferorelli S; Uricchio V; Colabufo NA; Niso M; Perrone R
J Med Chem; 2009 Dec; 52(23):7817-28. PubMed ID: 19842660
[TBL] [Abstract][Full Text] [Related]
6. 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity.
Berardi F; Ferorelli S; Abate C; Colabufo NA; Contino M; Perrone R; Tortorella V
J Med Chem; 2004 Apr; 47(9):2308-17. PubMed ID: 15084129
[TBL] [Abstract][Full Text] [Related]
7. The sigma-1 receptor antagonist PB212 reduces the Ca²⁺-release through the inositol (1, 4, 5)-trisphosphate receptor in SK-N-SH cells.
Gasparre G; Abate C; Berardi F; Cassano G
Eur J Pharmacol; 2012 Jun; 684(1-3):59-63. PubMed ID: 22465185
[TBL] [Abstract][Full Text] [Related]
8. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
Huang S; Qi P; Zhang T; Li F; He X
Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
[TBL] [Abstract][Full Text] [Related]
9. RNA interference against TMEM97 inhibits cell proliferation, migration, and invasion in glioma cells.
Qiu G; Sun W; Zou Y; Cai Z; Wang P; Lin X; Huang J; Jiang L; Ding X; Hu G
Tumour Biol; 2015 Sep; 36(10):8231-8. PubMed ID: 26002575
[TBL] [Abstract][Full Text] [Related]
10. Quantum Dot Based Luminescent Nanoprobes for Sigma-2 Receptor Imaging.
Pati ML; Fanizza E; Hager S; Groza D; Heffeter P; Laurenza AG; Laquintana V; Curri ML; Depalo N; Abate C; Denora N
Mol Pharm; 2018 Feb; 15(2):458-471. PubMed ID: 29226684
[TBL] [Abstract][Full Text] [Related]
11. Methyl substitution on the piperidine ring of N-[omega-(6-methoxynaphthalen-1-yl)alkyl] derivatives as a probe for selective binding and activity at the sigma(1) receptor.
Berardi F; Ferorelli S; Abate C; Pedone MP; Colabufo NA; Contino M; Perrone R
J Med Chem; 2005 Dec; 48(26):8237-44. PubMed ID: 16366605
[TBL] [Abstract][Full Text] [Related]
12. Induction of Mitochondrial Dysfunction and Oxidative Damage by Antibiotic Drug Doxycycline Enhances the Responsiveness of Glioblastoma to Chemotherapy.
Tan Q; Yan X; Song L; Yi H; Li P; Sun G; Yu D; Li L; Zeng Z; Guo Z
Med Sci Monit; 2017 Aug; 23():4117-4125. PubMed ID: 28842551
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a side population of astrocytoma cells in response to temozolomide.
Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C
J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
Mol Cancer Ther; 2015 Jul; 14(7):1559-69. PubMed ID: 25944918
[TBL] [Abstract][Full Text] [Related]
15. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
[TBL] [Abstract][Full Text] [Related]
16. Effects of pre-irradiation and SDF-1 suppression on the progression of murine astrocytoma cells grown in different stromal beds.
Yu CF; Lin CM; Wang SC; Chen FH; Hong JH; Tsai CS; Yang YC; Chiang CS
Int J Radiat Biol; 2014 Dec; 90(12):1162-8. PubMed ID: 24937369
[TBL] [Abstract][Full Text] [Related]
17. MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis.
Yang CH; Wang Y; Sims M; Cai C; He P; Yue J; Cheng J; Boop FA; Pfeffer SR; Pfeffer LM
Oncotarget; 2016 Dec; 7(51):84017-84029. PubMed ID: 27705947
[TBL] [Abstract][Full Text] [Related]
18. Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2-mediated signaling.
Sang Y; Hou Y; Cheng R; Zheng L; Alvarez AA; Hu B; Cheng SY; Zhang W; Li Y; Feng H
Neuro Oncol; 2019 Nov; 21(11):1423-1435. PubMed ID: 31232447
[TBL] [Abstract][Full Text] [Related]
19. The effects of new sigma (σ) receptor ligands, PB190 and PB212, in the models predictive of antidepressant activity.
Skuza G; Sadaj W; Kabziński M; Cassano G; Gasparre G; Abate C; Berardi F
Pharmacol Rep; 2014 Apr; 66(2):320-4. PubMed ID: 24911087
[TBL] [Abstract][Full Text] [Related]
20. Screening of anti-glioma effects induced by sigma-1 receptor ligands: potential new use for old anti-psychiatric medicines.
Mégalizzi V; Decaestecker C; Debeir O; Spiegl-Kreinecker S; Berger W; Lefranc F; Kast RE; Kiss R
Eur J Cancer; 2009 Nov; 45(16):2893-905. PubMed ID: 19679463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
